The table below shows PROCEPT BioRobotics Corp's cash flow statement by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
Line item
Q1 2026
Q1 2025
Q1 2024
Q1 2023
Q1 2022
Q1 2021
Operating cash flow
-$38.13M
-$16.98M
-$32.29M
-$35.93M
-$18.23M
-$15.20M
Capital expenditure
$2.91M
$1.84M
$1.95M
$5.34M
$55.00K
$39.00K
Investing cash flow
-$2.91M
-$1.84M
-$1.95M
-$5.34M
-$55.00K
-$39.00K
Dividends paid
-
-
-
PRCT operating cash flow (10-K history)
PROCEPT BioRobotics Corp reported operating cash flow of -$48.98M for fiscal year 2025. That is up 50.6% from -$99.21M in fiscal 2024. Over the 6 fiscal years shown, operating cash flow declined from -$48.34M (FY 2020) to -$48.98M. Figures come from the company's audited annual reports as filed with the SEC.